Fortress Biotech Just Netted $159 Million - Its Preferred Shares Could Be The Real Winner
Journey Medical Corp DERM
$6.37
▼ -1.24%
($-0.08)
🔥 High Short Interest
🗓️ Earnings Next Week
Open
$6.43
Prev Close
$6.45
Day Range
$6.20 – $6.54
52W Range
$4.31 – $9.56
Market Cap
$175.40M
Beta
1.07
EPS (TTM)
$-0.38
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-11-12 |
| Shares Out. | 21,530,000 |
| Website | journeymedicalcorp.com/ ↗ |
| Phone | 13025310855 |
| Employees | 58 |
| Revenue | $16.0M |
| Gross Profit | $9.7M |
| Net Income | -$2.2M |
| Total Assets | $91.5M |
| Total Liabilities | $60.7M |
| Equity | $30.8M |
About Journey Medical Corp
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
Journey Medical Corp is a publicly traded company under the ticker symbol DERM on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-07-01)